J. Romatowski

Gastric and pancreatic functions in haemodialyzed patients

A. Kemona, M. Myśliwiec, J. Małyszko, 2006, International Urology and Nephrology.

Increased plasma proteasome chymotrypsin-like activity in patients with advanced solid tumors

M. Wojtukiewicz, D. Hempel, H. Ostrowska, 2011, Tumor Biology.

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Fraser Cummings, S. Vermeire, E. Savarino, 2022, The Lancet.

Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial

K. Dilger, A. Dignass, R. Greinwald, 2018, United European gastroenterology journal.

The activity of lysosomal exoglycosidases in serum of alcohol-dependent men supplemented with borage oil enriched with vitamin E.

K. Zwierz, M. Knaś, S. Szajda, 2009, Journal of medicinal food.

Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study [102/120 characters including spaces].

E. Peeva, S. Danese, K. Hung, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis

Zhan Ye, M. Baniecki, S. Danese, 2021, Inflammatory bowel diseases.

Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study.

E. Peeva, W. Sandborn, S. Danese, 2023, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[The influence of the development of diabetes mellitus in patients with chronic pancreatitis on exocrine pancreatic function measured by secretin-caerulein test].

J. Romatowski, J. Stasiewicz, W. Szałaj, 2003, Polskie Archiwum Medycyny Wewnetrznej.

OP33 Oral ritlecitinib and brepocitinib in patients with Moderate to Severe Active Ulcerative Colitis: Data from the VIBRATO umbrella study

E. Peeva, S. Danese, K. Hung, 2021 .

Evaluation of feline leukemia virus control measures.

P. Kulesa, S. Lubkin, J. Romatowski, 1996, Journal of Theoretical Biology.

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.

A. Gasbarrini, B. Sands, I. Lawrance, 2023, Gastroenterology.